Patent directory · USPTO A61K / A61P
Patents matching “interleukin-”
120 pharma patents match "interleukin-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 120 pharmaceutical patents matching "interleukin-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11464830
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11421036
Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
granted -
US 11352403
Activatable interleukin-2 polypeptides and methods of use thereof
granted -
US 11352402
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 11318164
Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy
granted -
US 11118186
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 11098127
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 11091525
Method of refolding an interleukin-2 (IL-2) protein
granted -
US 11084856
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 11059896
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11041000
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11026997
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11013787
Sustained release formulation of interleukin-10 for wound treatment and related methods
granted -
US 11008314
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
granted -
US 11007265
Vaccines having an antigen and interleukin-21 as an adjuvant
granted -
US 10941183
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10933130
Vaccines with interleukin-33 as an adjuvant
granted -
US 10851158
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
granted -
US 10787490
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 10781242
Interleukin-2 fusion proteins and uses thereof
granted -
US 10738112
Anti-human interleukin-17A monoclonal antibody
granted -
US 10696724
Activatable interleukin-2 polypeptides
granted -
US 10611845
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
granted -
US 10435473
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted